Max Robotics — Global Service Robot Directory + US Certification

About

Guodong Zhao is a surgical innovator whose research sits at the intersection of robotic surgery, urological oncology, and hepatobiliary surgery. His most significant contributions center on advancing minimally invasive robotic techniques for complex, high-risk oncological procedures that have historically carried substantial morbidity. Zhao is perhaps best recognized for pioneering an intrapericardial control technique using robotic assistance for Level IV inferior vena cava thrombectomy in renal tumor patients — a landmark approach designed to reduce the severe complications traditionally associated with cardiopulmonary bypass and deep hypothermic circulatory arrest, a work that has garnered 16 citations since its 2022 publication. His single-center experience with robot-assisted nephrectomy and venous tumor thrombectomy, drawing on a cohort of 309 patients, further demonstrates his commitment to building evidence-based, long-term outcome data for challenging procedures. Beyond urological oncology, Zhao has extended robotic surgical innovation into hepatobiliary disease, describing robotic radical resection for the notoriously difficult Bismuth Type IVa hilar cholangiocarcinoma. Collectively, his work reflects a dedication to expanding the boundaries of what robotic surgery can safely achieve in complex cancer care.